Update on preparations of the European Partnership for Personalised Medicine

Update on preparations of the European Partnership for Personalised Medicine (EP PerMed) under Horizon Europe

European Partnerships (EP) are new instruments of the European Commission (EC) under the Horizon Europe framework programme, where national and regional funders join forces, strategies and budget in defined areas of action. So far, 49 EPs are foreseen in total and nine of these are in the Cluster “Health”. The European Partnership for Personalised Medicine, acronym: EP PerMed, is one of the proposed EPs and dedicated to personalised medicine (PM). Early this year, a draft proposal for the EP PerMed was already published by the EC.

Representatives of the Member States and Associated Countries to Horizon Europe met for the first time in-person on October 17-18, 2022 in Brussels to discuss about the upcoming partnership, the next steps to be taken in order to form the EP PerMed consortium and the SRIA development.

Strategic Research and Innovation Agenda (SRIA)

All European Partnerships have to develop a SRIA before their launch in order to ensure that their long-term vision is translated into concrete roadmaps with smart and measurable objectives. The EP PerMed Drafting Group currently identifies gaps, needs and challenges which should be addressed and overcome in the areas “research”, “innovation system” and “implementation” to foster Personalised Medicine for the benefit of patients and citizens. Information are gathered through different means from all related areas and sectors important for PM, i.e. focused expert interviews and analysis and consultation of strategic documents, both currently ongoing. A public online consultation is planned for November 2022 and a dedicated workshop in January 2023, the latter kindly supported by ICPerMed.

The next important steps in 2022 for the preparation of the EP PerMed are:

• SRIA Open Consultation, November 2022. ICPerMed will keep its newsletter subscribers updated about the launch of the open consultation.
• The finalisation of the first draft of the Personalised Medicine Strategic Research and Innovation Agenda (PM SRIA) end of 2022.
• The assembly of the EP PerMed consortium and the start of the EP PerMed proposal development, started in November 2022.
• The publication of the call for the co-funded European Partnership for Personalised Medicine end of 2022.

The EP PerMed proposal submission will take place in 2023 and the partnership is supposed to be launched by the end of 2023.

For any question around the EP PerMed, please contact the EP PerMed drafting group.

Contact details: eppermed@dlr.de